Section Arrow
Quote
JUNS.NASDAQ
- Jupiter Neurosciences Inc
(Financial Status)
Quotes are at least 15-min delayed:2026/04/02 12:20 EDT
Regular Hours
Last
 0.358
-0.0217 (-5.72%)
Day High 
0.37959 
Prev. Close
0.3797 
1-M High
0.5299 
Volume 
22.25K 
Bid
0.3636
Ask
0.3753
Day Low
0.358 
Open
0.358 
1-M Low
0.30615 
Market Cap 
13.07M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.37 
20-SMA 0.39 
50-SMA 0.52 
52-W High 3.33 
52-W Low 0.30615 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.23/-0.26
Enterprise Value
13.09M
Balance Sheet
Book Value Per Share
0.00
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
638.04K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
COCPCocrystal Pharma1.45+0.43+42.16%-- 
BDRXBiodexa Pharmaceuticals plc1.02+0.406+66.12%-- 
IOBTIO Biotech0.031-0.0127-29.06%-- 
INOInovio Pharmaceuticals1.0983-0.6417-36.88%-- 
GERNGeron Corp1.66------ 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.